Dr. Kento Sonoda, MD

Dr. Sonoda practices at SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri.

Dr. Sonoda's NPI, 1265926661, was assigned on June 19, 2018. Dr. Sonoda holds Missouri license 2022007809.

Dr. Sonoda's primary practice is SLUCare Physician Group Dermatology Pathology, at 1225 S Grand Blvd, 3rd Floor, Saint Louis, MO 63104. The practice phone is (314) 617-2709.

Dr. Sonoda's primary practice is SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri. Dr. Sonoda is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Sonoda to 2 more group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account. Dr. Sonoda's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sonoda practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Sonoda's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Sonoda's licenses on file in 2 states: Missouri and Pennsylvania.

CMS data shows 92 Medicare services from Dr. Sonoda across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $4,929 for them.

CMS counts 66 Medicare patients who saw Dr. Sonoda in 2024. The largest group is under 65, with 26 patients. 75% of them have high blood pressure, and 55% have high cholesterol. 74% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sonoda's median patient age at 59, with 50% women.

In 2024, Dr. Sonoda wrote 2,525 Medicare Part D claims for 223 patients. 83% of them were for generic drugs. CMS names the drug for 2,011 of them, across 59 drugs with 11 or more claims each, at $199,722 in total drug cost. In 2023, CMS named 617 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Sonoda for performance year 2024, reported as part of a group. Dr. Sonoda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sonoda as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Sonoda from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Indivior Inc. paid the most, $24.